Evaluation of a Smart Health Community for menopausal women in Australia - Pilot feasibility and acceptability study

Participants will be allocated to either the group + digital intervention, one to one + digital intervention or digital intervention alone. 1. Group Intervention The women in the Group Intervention will receive the digital intervention as well as a 1.5-hour telehealth meeting each week, with a Registered Nurse and General Practitioner, for 6 consecutive weeks. This meeting will be conducted via Telehealth and will be GP led and nurse supported. Session attendance checklists will be used to monitor attendance. The purpose of the Group appointment will be to enable women to share their lived experience of the Menopause, understand their clinical symptoms and engage in psychoeducation and behavioural interventions, to assist their transition. The digital intervention will serve as a prompt for exploring behaviours. i.e., which ever video they watched that week, we will encourage questions and explore motivation for change on that topic. Session attendance checklists will be used to monitor attendance. 2. One on one intervention Participants in the one-on-one program, will be enrolled in the Digital Intervention and undertake an additional 1-hour comprehensive assessment by a General Practitioner followed by a 6-week 30-minute telehealth behavioural coaching program. The one-on-one comprehensive assessment will be undertaken by a General Practitioner and Registered Nurse in a clinic setting. It will include Menopausal medical history, screening and health behaviour assessment and development of treatment plan according to patient centred goals. The following 6 weeks will involve a 30 min Telehealth consultation with a Naturopath or Registered Nurse. These consultations will be psychoeducation and motivational interviewing to encourage behavioural modification based on the treatment plan and prompted by the weekly digital content. If deemed clinically appropriate, the General Practitioner will also attend the sessions to answer any questions and guide the treatment plan. Session attendance checklists will be used to monitor attendance. All Telehealth is conducted via the functionality embedded within the secure Electronic Health Record. All Face-to-face clinical encounters will be conducted in a COVID safe manner. The clinical team will not be engaging in the prescribing of Menopausal Hormonal Therapy or any other Medication, for the purpose of this trial. The General Practitioner will oversee all levels of care and refer to the participants regular General Practitioner, via written communication, any areas of clinical concern that are outside the scope of this trial.